期刊文献+

卡马西平固体脂质纳米粒的包封率测定 被引量:1

Determination of Encapsulation Efficiencies of Carbamazepine Solid Lipid Nanoparticle
原文传递
导出
摘要 目的:建立以高效液相色谱法测定卡马西平固体脂质纳米粒含量并计算包封率的方法。方法:色谱柱为KromasilC18,流动相为甲醇-水(6∶4,含0.1%三乙胺),流速为1.0mL·min-1,检测波长为285nm,进样量为20μL。结果:卡马西平检测浓度的线性范围为0.525~21.0μg·mL-1(r=0.9998);平均回收率为100.1%(RSD=1.42%);平均包封率为73.1%。结论:本方法简便、快速、重现性好,可用于该制剂的质量控制。 OBJECTIVE: To establish an HPLC method for the determination of the content and calculated its encapsulation efficiency of carbamazepine solid lipid nanoparticle (SLN) . METHODS: The separation was performed on Kromasil C18 column. The mobile phase consisted of methanol- water (6 : 4, containing 0.1% triethylamine) with a flow rate of 1.0 mL · min ^-1. The detection wavelength was set at 285 nm and the injection volume was 20μL. RESULTS: The calibration curve was liner in the range of 0.525--21.0μg · mL^-(r =0.999 8). The average recovery was 100.1% (RSD = 1.42%) and the average encapsulation efficiency was 73.1%. CONCLUSION: The method is simple, rapid, and reproducible, and can be used for the quality control of carbamazepine solid lipid nanoparticles.
出处 《中国药房》 CAS CSCD 北大核心 2008年第13期1009-1011,共3页 China Pharmacy
基金 陕西省科技攻关项目(2004K10-G4(3))
关键词 卡马西平固体脂质纳米粒 高效液相色谱法 包封率 Carbamazepine solid lipid nanoparticles HPLC Encapsulation efficiency
作者简介 副主任药师,硕士。研究方向:医院制剂及新制剂。电话:029—87679336。E—mail:xzxxzx13@126.com
  • 相关文献

参考文献4

二级参考文献100

  • 1[1]Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism[J]. Eur J Pharm Biopharrn, 1998, 45(3): 149.
  • 2[2]Kopecek I, Kopeckoya P, Minko T. HPMA copolymer bound anticancer drug mechanism of action on cellular and subcellular levels [J]. Prog Int Symp Cont rolled Rel Bioact Mater, 1999,26 ( 1 ): 24.
  • 3[3]Torchilin VP. Liposomes as targetable drug carriers[J]. Crit Rev Ther Drug Carrier Syst, 1985,2(2): 65.
  • 4[4]Trotta M, Pattarino F, Ignoni T. Stability of drug-carrier emul sions containing phosphatidylcholine mixtures[J]. Eur J Pharm Biopharm, 2002,53(4): 203.
  • 5[5]MμLler RH, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles( SLN)-an alternative colloidal carrier system for controlleddrug delivery[J ]. Eur J Pharm Biopharm, 1995,41 (2): 62.
  • 6[6]Jahmke S. The theory of high pressure homogenization[ M]. in:Muller RH, Benita S, Emulsion and nanosuspensions for the for mulation of poorly soluble drugs. Medpharm Scientific Publish ers, stuttgart, B Bohm(Eds), 1998.177.
  • 7[7]Antonio JA, Runge S, Muller RH. Peptide-loaded solid lipid nanoparticles(SLN): influence of production parameters[J]. Int J Pharm, 1997, 149(6):255.
  • 8[8]Siekmann B, Westesen K. Investigation on solid lipid nanoparti cles prepared by precipitation in O/W emulsion[J]. Eur J Pharm Biopharm, 1996,43(2): 104.
  • 9[9]Gasco MS. Method for producing solid lipid nanospheres having a narrow size distribution[ P]. US Patent, 5250236, 1993-11-01.
  • 10[10]Muhlen A, Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles [ J ]. Pharmazie, 1998,53(11): 552.

共引文献31

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部